Literature DB >> 17006761

Mini review: immune response to myelin-derived sulfatide and CNS-demyelination.

Ramesh C Halder1, A Jahng, I Maricic, Vipin Kumar.   

Abstract

Here we briefly review our understanding of the immune response to myelin-derived glycolipids during an inflammatory autoimmune response in the central nervous system (CNS). We focus primarily on the recognition of the self-glycolipid sulfatide by a distinct population of non-invariant NK T cells. The results of studies we have obtained so far in investigating the presentation of sulfatide by CNS-resident cells including microglia and their interactions with T cells indicate that this pathway might be successfully targeted for the treatment of autoimmune demyelination in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006761     DOI: 10.1007/s11064-006-9145-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

Review 1.  Brain-immune connection: immuno-regulatory properties of CNS-resident cells.

Authors:  B Becher; A Prat; J P Antel
Journal:  Glia       Date:  2000-02-15       Impact factor: 7.452

2.  CD1b is expressed in multiple sclerosis lesions.

Authors:  L Battistini; F R Fischer; C S Raine; C F Brosnan
Journal:  J Neuroimmunol       Date:  1996-07       Impact factor: 3.478

3.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

Authors:  Jochen Mattner; Kristin L Debord; Nahed Ismail; Randal D Goff; Carlos Cantu; Dapeng Zhou; Pierre Saint-Mezard; Vivien Wang; Ying Gao; Ning Yin; Kasper Hoebe; Olaf Schneewind; David Walker; Bruce Beutler; Luc Teyton; Paul B Savage; Albert Bendelac
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

4.  Self glycolipids as T-cell autoantigens.

Authors:  A Shamshiev; A Donda; I Carena; L Mori; L Kappos; G De Libero
Journal:  Eur J Immunol       Date:  1999-05       Impact factor: 5.532

Review 5.  Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.

Authors:  L Steinman
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

6.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

Authors:  Sawsan Youssef; Olaf Stüve; Juan C Patarroyo; Pedro J Ruiz; Jennifer L Radosevich; Eun Mi Hur; Manuel Bravo; Dennis J Mitchell; Raymond A Sobel; Lawrence Steinman; Scott S Zamvil
Journal:  Nature       Date:  2002-11-07       Impact factor: 49.962

7.  CSF and serum ganglioside antibody patterns in MS.

Authors:  A Stevens; M Weller; H Wiethölter
Journal:  Acta Neurol Scand       Date:  1992-11       Impact factor: 3.209

8.  Elevated ganglioside concentration in serum and peripheral blood lymphocytes from multiple sclerosis patients in remission.

Authors:  B A Sela; G Konat; H Offner
Journal:  J Neurol Sci       Date:  1982-04       Impact factor: 3.181

9.  Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis.

Authors:  Amjad A Ilyas; Zie-Wie Chen; Stuart D Cook
Journal:  J Neuroimmunol       Date:  2003-06       Impact factor: 3.478

10.  Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.

Authors:  Alex Jahng; Igor Maricic; Carlos Aguilera; Susanna Cardell; Ramesh C Halder; Vipin Kumar
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

View more
  21 in total

1.  Enhanced selectivity for sulfatide by engineered human glycolipid transfer protein.

Authors:  Valeria R Samygina; Alexander N Popov; Aintzane Cabo-Bilbao; Borja Ochoa-Lizarralde; Felipe Goni-de-Cerio; Xiuhong Zhai; Julian G Molotkovsky; Dinshaw J Patel; Rhoderick E Brown; Lucy Malinina
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

Review 2.  Different subsets of natural killer T cells may vary in their roles in health and disease.

Authors:  Vipin Kumar; Terry L Delovitch
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

3.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

Review 4.  Role of sulfatide in normal and pathological cells and tissues.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

Review 5.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

6.  Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system.

Authors:  Xin Sun; Xi Wang; Tianxiang Chen; Tianyi Li; Kai Cao; Andrew Lu; Yongxiong Chen; Dongming Sun; Jianhong Luo; Jianqing Fan; Wise Young; Yi Ren
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

7.  Proteomic strategies in multiple sclerosis and its animal models.

Authors:  Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2007-10-16       Impact factor: 3.494

8.  Diffusion tensor imaging of mouse brain stem and cervical spinal cord.

Authors:  Joong Hee Kim; Justin Haldar; Zhi-Pei Liang; Sheng-Kwei Song
Journal:  J Neurosci Methods       Date:  2008-09-11       Impact factor: 2.390

9.  Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.

Authors:  Maria Blomqvist; Sara Rhost; Susann Teneberg; Linda Löfbom; Thomas Osterbye; Manfred Brigl; Jan-Eric Månsson; Susanna L Cardell
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

10.  NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation.

Authors:  Rachael Viale; Randle Ware; Igor Maricic; Varun Chaturvedi; Vipin Kumar
Journal:  Curr Immunol Rev       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.